Goodwin Procter represented Candel Therapeutics, Inc. in the offering, and Wilmer Cutler Pickering Hale and Dorr represented the underwriters.Candel Therapeutics, Inc. (Nasdaq: CDL) announced the pricing…
Standard 1 Year Membership Required
You must be a Standard 1 Year member to access this content.
Already a member? Log in here
